124
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

, , , , , , , , , & show all
Pages 1193-1202 | Published online: 06 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Yan Wei, Jin Zhao, Jian Ming, Xuewu Zhang & Yingyao Chen. (2022) Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China. Patient Preference and Adherence 16, pages 2387-2398.
Read now
Laren D Tan, Nolan Nguyen, Abdullah Alismail & Mario Castro. (2022) Management of Uncontrolled Asthma: A Framework for Novel and Legacy Biologic Treatments. Journal of Asthma and Allergy 15, pages 875-883.
Read now
Michelle Dilley Revier & Bob Geng. (2022) Mepolizumab prefilled syringe for the treatment of severe eosinophilic asthma: focus on the pediatric population. Expert Review of Respiratory Medicine 16:8, pages 857-865.
Read now
James Hawthorne, Dimos Katsaros, Amy Rinaldi, Katherine Brigham, Matthew D’Auria, Erika Bajars, Chris Franzese & Marty Coyne. (2022) The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices. Expert Opinion on Drug Delivery 19:6, pages 733-742.
Read now
Virginia Solitano, Ludovico Alfarone, Ferdinando D’Amico, Laurent Peyrin-Biroulet & Silvio Danese. (2022) IBD goes home: from telemedicine to self-administered advanced therapies. Expert Opinion on Biological Therapy 22:1, pages 17-29.
Read now
Andreas Schneider, Philipp Richard, Philippe Mueller, Christoph Jordi, Mary Yovanoff & Jakob Lange. (2021) User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces. Patient Preference and Adherence 15, pages 159-168.
Read now
Jakob Lange, Andreas Schneider, Christoph Jordi, Michael Lau & Timothy Disher. (2021) Formative Study on the Wearability and Usability of a Large-Volume Patch Injector. Medical Devices: Evidence and Research 14, pages 363-377.
Read now
Jesús Tornero Molina, Juan Carlos López Robledillo & Núria Casamira Ruiz. (2021) Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review. Drug, Healthcare and Patient Safety 13, pages 81-94.
Read now
Ubaldo J. Martin, Rainard Fuhr, Pablo Forte, Peter Barker, Milton J. Axley, Magnus Aurivillius, Li Yan & Lorin Roskos. (2021) Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results. Journal of Asthma 58:1, pages 93-101.
Read now
HoUng Kim, Rieke Alten, Fraser Cummings, Silvio Danese, Geert D’Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, JongHyuk Lee, James O. Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven Simoens, Rene Westhovens, Ji Hoon Jeong & Laurent Peyrin-Biroulet. (2021) Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs 13:1.
Read now
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, Paul Roussel, Peter Barker & Ubaldo J Martin. (2019) Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results. Journal of Asthma and Allergy 12, pages 363-373.
Read now
Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Rainard Fuhr, Thomas Koernicke, Ellen Schuck, Maria Velinova, Andrej Skerjanec, Johann Poetzl & Julia Jauch-Lembach. (2019) GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods. Expert Opinion on Biological Therapy 19:10, pages 1075-1083.
Read now
Bart J. F. van den Bemt, Lynda Gettings, Barbara Domańska, Richard Bruggraber, Irina Mountian & Lars E. Kristensen. (2019) A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Delivery 26:1, pages 384-392.
Read now

Articles from other publishers (17)

Kyle Berman, Simon Moss, Barry Holden-Theunissen, Nobuhiko Satou, Kenji Okada, Mark Latymer & Attila Antalfy. (2023) Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies. Advances in Therapy 40:7, pages 3070-3086.
Crossref
Lisa Pivato, Daniele Mengato, Federica Torni, Claudia Battistutta, Francesca Temporin & Francesca Venturini. (2023) Factors influencing the acceptability of different devices for subcutaneous drug delivery: a cross-sectional observational study from the patient’s point of view. European Journal of Hospital Pharmacy, pages ejhpharm-2022-003477.
Crossref
Beate Bittner. (2023) Customer-centric product presentations for monoclonal antibodies. AAPS Open 9:1.
Crossref
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama & Yasuo Suzuki. (2022) Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance. Intestinal Research 20:3, pages 329-341.
Crossref
Anthony Andre, Nicholas Squittieri & Satyashodhan Patil. (2022) Evaluating Use of the Octreotide Acetate Pen Injector in a Summative Human Factors Validation Study. Endocrine Practice 28:4, pages 414-419.
Crossref
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics 85 105 .
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics 1 46 .
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics 153 174 .
Ferdinando D'Amico, Virginia Solitano, Daniel Aletaha, Ailsa Hart, Fernando Magro, Carlo Selmi, Siew C. Ng, Sameer Al Awadhi, Ernest Choy, Hendrik Schulze-Koops, Peter Bossuyt, Pablo A. Olivera, Paulo Gustavo Kotze, Subrata Ghosh, Laurent Peyrin-Biroulet & Silvio Danese. (2021) Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus. Autoimmunity Reviews 20:7, pages 102849.
Crossref
Wenhui Zhang, Helen Tyrrell, Han Ting Ding, Jennifer Pulley, Audrey Boruvka, Rich Erickson, Mariam Abouhossein, Renato Ravanello & Meina Tao Tang. (2021) Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. Advances in Therapy 38:5, pages 2418-2434.
Crossref
Helen Tyrrell, Renato Ravanello, Jennifer Pulley, Meina Tao Tang, Wenhui Zhang, Mariam Abouhossein & Swati Tole. (2021) An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers. Advances in Therapy 38:5, pages 2406-2417.
Crossref
Cristina Martínez-Múgica Barbosa, Belén Rodríguez de Castro, Yoar Labeaga Beramendi, Paloma Terroba Alonso & Javier Barbazán Vázquez. (2021) Patient satisfaction survey: substitution of reference etanercept with a biosimilar product. European Journal of Hospital Pharmacy 28:2, pages 109-111.
Crossref
R. Mallick, T. Henderson, B. J. Lahue, A. Kafal, P. Bassett & C. Scalchunes. (2020) Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes. BMC Immunology 21:1.
Crossref
Anja St Clair-Jones, Francesca Prignano, Joao Goncalves, Muriel Paul & Philipp Sewerin. (2020) Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review. Rheumatology and Therapy 7:4, pages 741-757.
Crossref
Michaël Somers, Peter Bossuyt, Marc Ferrante, Harald Peeters & Filip Baert. (2020) Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 14:5, pages 680-685.
Crossref
Rajagopalan Vijayaraghavan. (2020) Autoinjector device for rapid administration of drugs and antidotes in emergency situations and in mass casualty management. Journal of International Medical Research 48:5, pages 030006052092601.
Crossref
Peter Bossuyt, Filip Baert, Francois D’Heygere, Antoine Nakad, Catherine Reenaers, Fernand Fontaine, Denis Franchimont, Olivier Dewit, Philippe Van Hootegem, Stijn Vanden Branden, Guy Lambrecht, Marc Ferrante, Pieter Hindryckx, Elisabeth Macken, Philip Caenepeel, Anne Vijverman, Nicolas de Suray, Joris Dutré, Edouard Louis & Jean-Louis Coenegracths. (2019) Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort. Inflammatory Bowel Diseases 25:1, pages 156-162.
Crossref